Allergy/Asthma News

Theresa Bingemann, MD, FACAAI, FAAAAI, found a role that was perfect for her. Combining her passion for learning and teaching, the program director of University of Rochester’s Allergy and Immunology Fellowship was a dream career.

WASHINGTON — Children were desensitized to baked and unheated milk with 12 and 24 months of baked milk oral immunotherapy, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN DIEGO — In children aged 2 to 5 years with atopic dermatitis, roflumilast cream 0.05% significantly improved symptoms compared with vehicle, with improvement seen as early as 1 week after treatment, according to a speaker here.

WASHINGTON — Concentrations of indoor pest allergens were consistently associated with upper respiratory infections, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Allergic status did not impact annualized asthma exacerbation rate reductions seen with mepolizumab, benralizumab and tezepelumab in patients with moderate to severe, uncontrolled asthma, according to study results.

SAN DIEGO — In this video perspective, Menas Kizoulis, senior director of global scientific engagement at Kenvue, discusses the company’s latest research presented at the American Academy of Dermatology Annual Meeting.

WASHINGTON — Adults with peanut allergy safely used toothpaste infused with peanut protein as oral mucosal immunotherapy, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Asthma was the most common comorbidity associated with chronic cough in the findings of a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON —Tertiary care center providers generally reported similar asthma inhaler practices despite being from different disciplines, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN DIEGO — New data showed Vtama cream achieved consistent and strong efficacy for the treatment of atopic dermatitis across all racial groups, according to a poster presentation at the 2024 American Academy of Dermatology Annual Meeting.